At a glance
- Originator Ceridia
- Class Antimigraines; Antineoplastics; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 21 Sep 2023 Discontinued - Preclinical for Pain in Australia (PO)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Pain in Australia (PO)
- 12 Aug 2016 Chemical structure information added